Arab World vs United Kingdom: Access to anti-retroviral drugs, female (%)
Arab World
48.4%
in 2024
United Kingdom
96.0%
in 2023
Arab World rank
16th
United Kingdom rank
14th
Access to anti-retroviral drugs, female (%) over time
- Arab World
- United Kingdom
How they compare
United Kingdom currently reports 96.0% against 48.4% in Arab World, a difference of 47.6%.
That makes United Kingdom's figure about 2.0 times Arab World's.
Across all 8 years both countries report, United Kingdom has been ahead every year.
Arab World ranks 16th and United Kingdom ranks 14th of 19 groups.
United Kingdom has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Arab World | United Kingdom | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 38.8% | 88.0% | 49.2% | United Kingdom |
| 2020s | 46.5% | 90.8% | 44.2% | United Kingdom |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Arab World or United Kingdom?
- United Kingdom, at 96.0% against 48.4% in Arab World as of 2023.
- What is the difference in access to anti-retroviral drugs, female between Arab World and United Kingdom?
- 47.6%, with United Kingdom ahead.
- How many years of comparable data are there for Arab World and United Kingdom?
- 8 years are reported by both, from 2016 to 2023.
- How do Arab World and United Kingdom rank globally for access to anti-retroviral drugs, female?
- Arab World ranks 16th and United Kingdom ranks 14th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.